| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:2497-2505.)
© 2007 American Heart Association, Inc.
Heart Failure |
From Albert Einstein College of Medicine, Bronx, NY (S.M.); Columbia University College of Physicians and Surgeons, New York, NY (D.M., S.X.); Cleveland Clinic, Cleveland, Ohio (R.C.S.); University of Michigan Health System, Ann Arbor (K.A., F.D.P.); University of Minnesota, Minneapolis (L.W.M.); University of Pennsylvania, Philadelphia (K.M.); Texas Heart Institute, Houston (O.H.F.); and Methodist DeBakey Heart Center, Baylor College of Medicine, Houston, Tex (S.M., G.T.-A.). Dr Miller is currently at the Georgetown Hospital Center, Washington, DC.
Correspondence to Simon Maybaum, MD, Albert Einstein College of Medicine, Center for Advanced Cardiac Therapy, 3400 Bainbridge Ave, 7th Floor, Bronx, NY 10467-2490. E-mail smaybaum{at}montefiore.org
Received July 31, 2006; accepted March 4, 2007.
Background Myocardial recovery after left ventricular assist device (LVAD) support has been reported. The LVAD Working Group Recovery Study was a prospective multicenter trial to assess the incidence of myocardial recovery in patients bridged to cardiac transplantation.
Methods and Results After LVAD implantation, patients were evaluated with the use of rest echocardiograms with partial LVAD support and cardiopulmonary exercise testing. Dobutamine echocardiography with hemodynamic measurements was performed in those patients with left ventricular ejection fraction >40% during resting studies. Histological analysis was performed on myocardial samples taken at LVAD implantation and explantation. Sixty-seven LVAD patients with heart failure participated in the study. After 30 days, significant improvement occurred in left ventricular ejection fraction (17±7% versus 34±12%; P<0.001) and reductions in left ventricular end-diastolic diameter (7.1±1.2 versus 5.1±1.1 cm; P<0.001) and left ventricular mass (320±113 versus 194±79 g; P<0.001) compared with before LVAD. Thirty-four percent of patients had left ventricular ejection fraction >40% with partial device support. Left ventricular ejection fraction decreased over time to pre-LVAD measurement by 120 days. Peak
O2 improved with mechanical support (13.7±4.2 versus 18.9±5.5 mL/kg per minute, 30 versus 120 days; P<0.001). Tissue analysis revealed significant reductions in myocyte size, collagen content, and cardiac tumor necrosis factor-
. Six subjects (9%) underwent LVAD explantation for recovery.
Conclusions Cardiac function improves significantly after device implantation. Although cellular recovery and improvement in ventricular function are observed, the degree of clinical recovery is insufficient for device explantation in most patients with chronic heart failure.
Related Article:
This article has been cited by other articles:
![]() |
K. R. McGaffin, C. S. Moravec, and C. F. McTiernan Leptin Signaling in the Failing and Mechanically Unloaded Human Heart Circ Heart Fail, November 1, 2009; 2(6): 676 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Klotz, D. Burkhoff, I. M. Garrelds, F. Boomsma, and A.H.J. Danser The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Eur. Heart J., April 1, 2009; 30(7): 805 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Willis, M. Rojas, L. Li, C. H. Selzman, R.-H. Tang, W. E. Stansfield, J. E. Rodriguez, D. J. Glass, and C. Patterson Muscle ring finger 1 mediates cardiac atrophy in vivo Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H997 - H1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Siedlecka, M. Arora, T. Kolettis, G. K. R. Soppa, J. Lee, M. A. Stagg, S. E. Harding, M. H. Yacoub, and C. M. N. Terracciano Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1917 - H1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Jones The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1707 - 1718. [Full Text] [PDF] |
||||
![]() |
G. K.R. Soppa, J. Lee, M. A. Stagg, L. E. Felkin, P. J.R. Barton, U. Siedlecka, S. Youssef, M. H. Yacoub, and C. M.N. Terracciano Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure Cardiovasc Res, March 1, 2008; 77(4): 695 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Davies Invited commentary Ann. Thorac. Surg., October 1, 2007; 84(4): 1262 - 1263. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |